UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development of a recombinant murine tumour model using hepatoma cells expressing hepatitis C virus nonstructural antigens

Journal of viral hepatitis, 2018-06, Vol.25 (6), p.649-660

2018

Volltextzugriff (PDF)

CpG DNA induces stronger immune responses with less toxicity than other adjuvants

Vaccine, 2000-03, Vol.18 (17), p.1755-1762

2000

Volltextzugriff (PDF)

Development of AVID200, a novel TGF-β targeting immunotherapy: Characterization of immunomodulatory effects

European journal of cancer (1990), 2016-12, Vol.69, p.S105-S105

2016

Volltextzugriff (PDF)

Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo

The Journal of immunology (1950), 2000-02, Vol.164 (3), p.1617-1624

2000

Volltextzugriff (PDF)

Sequence Motifs in Adenoviral DNA Block Immune Activation by Stimulatory CpG Motifs

Proceedings of the National Academy of Sciences - PNAS, 1998-10, Vol.95 (21), p.12631-12636

1998

Volltextzugriff (PDF)

Treatment of intravaginal HSV-2 infection in mice: A comparison of CpG oligodeoxynucleotides and resiquimod (R-848)

Antiviral research, 2006-02, Vol.69 (2), p.77-85

2006

Volltextzugriff (PDF)

Designing gene therapy vectors: avoiding immune responses by using tissue-specific promoters

Gene therapy, 2001-12, Vol.8 (24), p.1872-1878

2001

Volltextzugriff (PDF)

CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans

Vaccine, 2000-03, Vol.18 (18), p.1920-1924

2000

Volltextzugriff (PDF)

Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs

Gene therapy, 2001-07, Vol.8 (13), p.1024-1032

2001

Volltextzugriff (PDF)

CpG DNA is an effective oral adjuvant to protein antigens in mice

Vaccine, 2000-11, Vol.19 (7), p.950-957

2000

Volltextzugriff (PDF)

Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution

Molecular medicine (Cambridge, Mass.), 2000-10, Vol.6 (10), p.867-877

2000

Volltextzugriff (PDF)

CPG ODN allows lower dose of antigen against hepatitis B surface antigen in BALB c mice

Immunology and cell biology, 2003-02, Vol.81 (1), p.59-62

2003

Volltextzugriff (PDF)

Immune-mediated destruction of transfected myocytes following DNA vaccination occurs via multiple mechanisms

Gene therapy, 2001-09, Vol.8 (18), p.1395-1400

2001

Volltextzugriff (PDF)

Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities

European journal of immunology, 2004-01, Vol.34 (1), p.251-262

2004

Volltextzugriff (PDF)

The role of CpG in DNA vaccines

Seminars in immunopathology, 2000-03, Vol.22 (1-2), p.125-132

2000

Volltextzugriff (PDF)

The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants

Vaccine, 2001-03, Vol.19 (17), p.2657-2660

2001

Volltextzugriff (PDF)

Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants

Vaccine, 2001-06, Vol.19 (27), p.3759-3768

2001

Volltextzugriff (PDF)

Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity

Journal of leukocyte biology, 2004-09, Vol.76 (3), p.585-593

2004

Volltextzugriff (PDF)

Testing of CpG-Optimized Protein and DNA Vaccines against the Hepatitis B Virus in Chimpanzees for Immunogenicity and Protection from Challenge

Intervirology, 2006-01, Vol.49 (3), p.144-151

2006

Volltextzugriff (PDF)

318 - Development of AVID200, a novel TGF-β targeting immunotherapy: Characterization of immunomodulatory effects

European journal of cancer (1990), 2016-12, Vol.69, p.S105-S105

2016

Volltextzugriff (PDF)

Development of AVID200, a novel TGF-ß targeting immunotherapy: Characterization of immunomodulatory effects

European journal of cancer (1990), 2016-12, Vol.69, p.S105

2016

Volltextzugriff (PDF)

Sequences derived from self-RNA containing certain natural modifications act as suppressors of RNA-mediated inflammatory immune responses

International immunology, 2009-05, Vol.21 (5), p.607-619

2009

Volltextzugriff (PDF)

CpG DNA can Induce Strong Th1 Humoral and Cell-Mediated Immune Responses against Hepatitis B Surface Antigen in Young Mice

Proceedings of the National Academy of Sciences - PNAS, 1998-12, Vol.95 (26), p.15553-15558

1998

Volltextzugriff (PDF)

Detection and production of verotoxin 1 of Escherichia coli O157:H7 in food

Applied and Environmental Microbiology, 1991-10, Vol.57 (10), p.2951-2955

1991

Volltextzugriff (PDF)

CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice

FEMS immunology and medical microbiology, 2001-12, Vol.32 (1), p.65-71

2001

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(56)

Sprache

Englisch
(56)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(40)
Animals
(39)
Immunology
(30)
Mice
(29)
Mice, Inbred Balb C
(26)
Female
(22)
Biological And Medical Sciences
(19)
Fundamental And Applied Biological Sciences. Psychology
(17)
Humans
(16)
Microbiology
(16)
Antigens
(13)
Medicine, Research & Experimental
(13)
Research & Experimental Medicine
(13)
Hepatitis B Surface Antigens - Immunology
(12)
Immunization
(12)
Oligodeoxyribonucleotides - Immunology
(12)
Cpg Islands - Immunology
(11)
Infectious Diseases
(11)
Vaccines
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development of a recombinant murine tumour model using hepatoma cells expressing hepatitis C virus nonstructural antigens

CpG DNA induces stronger immune responses with less toxicity than other adjuvants

Development of AVID200, a novel TGF-β targeting immunotherapy: Characterization of immunomodulatory effects

Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo

Sequence Motifs in Adenoviral DNA Block Immune Activation by Stimulatory CpG Motifs

Treatment of intravaginal HSV-2 infection in mice: A comparison of CpG oligodeoxynucleotides and resiquimod (R-848)

Designing gene therapy vectors: avoiding immune responses by using tissue-specific promoters

CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans

Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs

CpG DNA is an effective oral adjuvant to protein antigens in mice

Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution

CPG ODN allows lower dose of antigen against hepatitis B surface antigen in BALB c mice

Immune-mediated destruction of transfected myocytes following DNA vaccination occurs via multiple mechanisms

Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities

The role of CpG in DNA vaccines

The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants

Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants

Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity

Testing of CpG-Optimized Protein and DNA Vaccines against the Hepatitis B Virus in Chimpanzees for Immunogenicity and Protection from Challenge

318 - Development of AVID200, a novel TGF-β targeting immunotherapy: Characterization of immunomodulatory effects

Development of AVID200, a novel TGF-ß targeting immunotherapy: Characterization of immunomodulatory effects

Sequences derived from self-RNA containing certain natural modifications act as suppressors of RNA-mediated inflammatory immune responses

CpG DNA can Induce Strong Th1 Humoral and Cell-Mediated Immune Responses against Hepatitis B Surface Antigen in Young Mice

Detection and production of verotoxin 1 of Escherichia coli O157:H7 in food

CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice

Suchergebnisse filtern